CD79A and COVID-19: Hence, in this study, we measured the presence of S1 specific IgM, IgG and IgA in sera from naturally infected COVID-19 patients, COVID-19 naïve Pfizer and Sinopharm vaccinated personnel, and a group of random individuals.